Rapid Analysis of Mycophenolic Acid in Human Plasma Using an Agilent Triple Quadrupole LC/MS/MS System with Automated Online Sample Cleanup

Significance of the Topic

Reliable measurement of mycophenolic acid (MPA) in human plasma is critical for therapeutic drug monitoring of immunosuppressants, pharmacokinetic studies and ensuring patient safety. Accurate differentiation from its glucuronide metabolite (MPA-G) prevents quantitation errors due to in-source fragmentation and supports robust clinical research.

Objectives and Study Overview

This study aimed to develop a rapid, sensitive and specific LC-MS/MS method for quantifying MPA in human plasma with automated on-line sample cleanup. Key goals included:

• Achieve complete chromatographic separation of MPA and MPA-G within a 4-minute total run time
• Implement a simple protein precipitation protocol combined with automated trapping for matrix removal
• Validate linearity, accuracy and precision across clinically relevant concentration ranges (0.1–25 µg/mL)

Methodology and Instrumentation

• Sample Preparation: Plasma aliquot (100 µL) mixed with 200 µL ZnSO₄:methanol (1:4) containing deuterated MPA internal standard; vortexed, centrifuged at 10,000 rpm for 4 min and supernatant transferred for injection.
• Liquid Chromatography: Agilent 1260 Infinity with two binary pumps and a 2-position/6-port valve; trapping column ZORBAX Eclipse Plus C18 (2.1×12.5 mm, 5 µm); analytical column Poroshell 120 EC-C18 (3×50 mm, 2.7 µm); run time 2 min; gradient loading and elution optimized for on-line cleanup.
• Mass Spectrometry: Agilent 6460 Triple Quadrupole with JetStream ESI in positive mode; MRM transitions: MPA (321.1→207.0), MPA-G (514.2→207.0), MPA-d3 IS (324.2→210.1); source parameters: drying gas 9 L/min (225 °C), sheath gas 12 L/min (325 °C), capillary voltage 4 kV; data processed with MassHunter Quantitative Software (1/x weighting).

Results and Discussion

The method demonstrated excellent linearity for MPA (0.1–25 µg/mL) and MPA-G (0.49–125 µg/mL) with R² ≥ 0.993. Retention time reproducibility showed RSD <0.5%, ensuring accurate peak differentiation. Intra- and inter-day accuracy ranged from 98% to 105% with CVs below 4.5%. Extracted MRM chromatograms confirmed clear separation of MPA from in-source MPA-G fragments, eliminating quantitation bias.

Benefits and Practical Applications

• Rapid throughput with a 4-minute analysis cycle and minimal sample preparation
• Automated online cleanup reduces matrix effects and instrument downtime
• High specificity via MRM and deuterated internal standardization enhances quantitation reliability
• Applicable to therapeutic drug monitoring, pharmacokinetic profiling and clinical research

Future Trends and Applications

• Extension of automated cleanup and rapid LC-MS/MS workflows to multiplex assays for multiple immunosuppressants
• Integration with high-throughput platforms and laboratory information systems for clinical diagnostics
• Adaptation to alternative matrices such as dried blood spots or microdialysates
• Advancements in source technology and software for real-time data analysis and remote monitoring

Conclusion

A fast, robust and highly selective LC-MS/MS method for MPA quantitation in human plasma has been established. The protocol combines simple protein precipitation with automated on-line cleanup and MRM detection to deliver accurate results across a clinically relevant range, supporting efficient therapeutic monitoring and research applications.

References

1. Rapid Analysis of Mycophenolic Acid in Human Plasma Using an Agilent Triple Quadrupole LC/MS/MS System with Automated Online Sample Cleanup. Agilent Technologies, Inc. Application Note, July 2014.